X

In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software

Published Date: June 2021 | Report Code : HC2169815

X

In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models), Toxicity End Point and Test (Absorption, Distribution, Metabolism, and Excretion (ADME), Skin Irritation, Corrosion and Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Others), End User (Pharmaceuticals and Biopharmaceuticals, Cosmetic and Household Products, Food, Chemicals, and Others), Technology (Cell Culture Technologies, High-throughput Technologies, Toxicogenomics), and Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size and Forecasting to 2030

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2169815

Status : Published June 2021

The Global In Vitro Toxicology Testing Market has been estimated to reach a value of USD 13,800.5 million in 2021 and is projected to grow at a CAGR of 11.2% during the forecast period. In vitro toxicology can be defined as the toxicological phenomena studied in nonwhole animal models. This broad connotation comprises explants cultures, isolated organs, isolated primary cell cultures, tissue slices, cell lines, and even subcellular fractions like that of mitochondria, microsomes, and even membranes.

In vitro tests offer toxicity information in a time-saving and cost-effective manner. The rapid advancement in biomedical sciences is expected to drive advanced and new in vitro test strategies for hazard characterization. Toxicology testing is becoming proficient with different advanced technologies supporting the process. This test is mandated for evaluating the safety of drug development. Currently, it is poised to take advantage of promising revolutions from the field of biotechnology.

Technological advancements in the in vitro toxicology assays, increasing awareness regarding drug product safety, and increasing R&D expenditure to detect toxicity at an early stage during drug development, opposition to the use of animals in pre-clinical trials are expected to drive the market growth. Drug novelty and customization in medicines by deploying in vitro drugs are a frontrunner to the in vitro toxicology testing market growth.

Strict regulations by government on in vitro toxicology testing are expected to restrain the market growth during the forecast period. The incapability of in vitro models to regulate immunostimulation and autoimmunity are also expected to hinder the market growth during the forecast period.

Due to outbreak of COVID-19, there has been a major rise in COVID-19 testing and drug research. In the research and development sector, understanding the dynamics of the infection better is anticipated to drive the in vitro toxicology research field. However, the major share of molecular testing and diagnostic assays of COVID-19, along with personalized medicine is expected to grow at a stable pace in the next six years.

There is a massive rise in the number of manufacturers that have taken major steps to increase patient access to coronavirus diagnostic testing, drug development in laboratories, vaccine, hospitals and other testing sites across the country to protect public health and guide patient care. These factors are expected to have a positive impact on the market during the forecast period.

                     TABLE 1: GLOBAL IN VITOR TOXICOLOGY OVERALL SNAPSHOT

In Vitro Toxicology Testing Market table 1

Market Segmentation

The global in vitro toxicology testing market report has been segmented into product and service, methods, toxicity endpoint and test, industry, technology, and region.

FIGURE 1: GLOBAL IN VITRO TOXICOLOGY MARKET SEGMENTATION

Global In Vitro Toxicology Testing Market, by Product and Service:

Based on product and service, the market is segmented into consumables, assays, equipment, software, and services. The assay segment is further segmented into bacterial toxicity assays, enzyme toxicity assays, cell-based ELISA and western blots, receptor-binding assays, tissue culture assays, and others.

The consumable segment of in vitro toxicology testing market holds the largest market share in 2021 and is expected to remain the largest segment till the forecast period. The segment growth can be attributed to use of high-quality reagents, repeated use of reagents, and media in vitro toxicology studies, these factors will drive the market growth in the forecast period.

Global In Vitro Toxicology Testing Market, by Methods:

Based on methods, the in vitro toxicology testing market is segmented into cellular assays, biochemical assays, in silico models, and ex vivo models.

Among these segments, the in silico models method and in vitro models have been observed as recent trends in the in vitro toxicity testing market, and witness substantial growth, in the year 2021, due to their rapid adoption and technological advancement in these segments.

Global In Vitro Toxicology Testing Market, by Toxicity Endpoint and Test

Based on toxicity endpoint and test, the in vitro toxicology testing market is segmented into Absorption, Distribution, Metabolism, and Excretion (ADME), skin irritation, corrosion, and sensitization, genotoxicity testing, cytotoxicity testing, ocular toxicity, organ toxicity, phototoxicity testing, dermal toxicity, and others.

The organ toxicity segment is expected to grow at the highest CAGR in 2021 and is expected to continue its growth during the forecast period. The segment growth can be attributed to factors, such as the increasing focus on consumer-product safety, drug safety, and the need to screen potential drug targets in the initial stage of drug development.

Global In Vitro Toxicology Testing Market, by End User

Based on end user, the in vitro toxicology testing market is segmented into pharmaceuticals and biopharmaceuticals, cosmetic and household products, food, and chemicals.

The pharmaceutical and biopharmaceuticals segment of in vitro toxicology testing market is expected to hold the largest market share in 2021 and is expected to remain the largest segment till the forecast period. The segment growth can be attributed to toxicological testing being an essential step for drug development.

Global In Vitro Toxicology Testing Market, by Technology

Based on technology, the in vitro toxicology testing market is segmented into cell culture technologies, high-throughput technologies, and toxicogenomics.

The cell culture segment of in vitro toxicology testing market is expected to capture the largest market share in 2021 and is expected to remain the largest segment till the forecast period. The large share can be attributed to highly preferred techniques for toxicity testing and the ability of cell cultures of mimicking in vivo conditions.

Global In Vitro Toxicology Testing Market, by Region

Based on region, the in vitro toxicology testing market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America.

Asia Pacific is expected to register the highest growth during the forecast period. The growth can be attributed to factors such as opposition to animal testing resulting in the use of alternate methods, and emergence of Contract Research Organization (CROs) for outsourcing toxicology-related research projects. Growing consumer awareness about product safety and growing pharmaceutical drug pipeline are some of major factors propelling the Asia Pacific in vitro toxicology testing market.

TABLE 2: GLOBAL IN VITRO TOXICOLOGY MARKET OVERVIEW

In Vitro Toxicology Testing Market table 2 

FIGURE 2: GLOBAL IN VITRO TOXICOLOGYMARKET (USD MILLION), 2021-2030

In Vitro Toxicology Testing Market

Recent Developments in the Global In Vitro Toxicology Testing Market

  • September, 2019- Covance in Shanghai opened a new R&D center in China to boost the in vitro toxicology testing market in Asia Pacific region.
  • August, 2019- Abbott signed an agreement with Intoximeters to market Abbott's SoToxa Mobile Test System, a handheld oral fluid solution for alcohol and drug testing in U.S. The product allows the testing of benzodiazepines, methamphetamine, amphetamine, cocaine, opiates, and cannabis (THC).
  • August, 2019- Covance introduced a laboratory solution in its functional service provider (FSPx) offering, including clinical operations capabilities, and a clinical analytics service.
  • August, 2019- Merck acquired a German laboratory informatics company, BSSN Software for ease of collaboration, data integration, analysis, and long-term archiving in laboratories.
  • May, 2018- A new food testing laboratory, Eurofins opened in Suzhou, China with a capitalization of (EUR 3 million) to increase its presence in the Asia Pacific.

What Does This Report Provide?

This report provides a detailed understanding of the global in vitro toxicology testing market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market. The major market drivers, challenges, and opportunities for the global in vitro toxicology testing market have been covered in the report. This report further includes the market shares of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Market Segmentation:

By Product and Service

  • Consumables
  • Assays
    • Bacterial Toxicity Assays
    • Enzyme Toxicity Assays
    • Cell-based ELISA and Western Blots
    • Receptor-binding Assays
    • Tissue Culture Assays
    • Others
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays 
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint and Test

  • Absorption, Distribution, Metabolism, and Excretion (ADME)
  • Skin Irritation, Corrosion, and Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Others

By End User

  • Pharmaceuticals and Biopharmaceuticals
  • Cosmetic and Household Products
  • Food
  • Chemicals

By Technology

  • Cell Culture Technologies 
  • High-throughput Technologies 
  • Toxicogenomics

By Region

North America In Vitro Toxicology Testing Market

  • North America, by Country
    • U.S.
    • Canada
    • Mexico
  • North America, by Product and Service
  • North America, by Methods
  • North America, by Toxicity Endpoint and Test
  • North America, by End User
  • North America, by Technology

Europe In Vitro Toxicology Testing Market

  • Europe, by Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe 
  • Europe, by Product and Service
  • Europe, by Methods
  • Europe, by Toxicity Endpoint and Test
  • Europe, By End User
  • Europe, By Technology

Asia Pacific In Vitro Toxicology Testing Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific 
  • Asia Pacific, by Product and Service
  • Asia Pacific, by Methods
  • Asia Pacific, by Toxicity Endpoint and Test
  • Asia Pacific, by End User
  • Asia Pacific, by Technology

Middle East and Africa In Vitro Toxicology Testing Market

  • Middle East and Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East and Africa
  • Middle East and Africa, by Product and Service
  • Middle East and Africa, by Methods
  • Middle East and Africa, by Toxicity Endpoint and Test
  • Middle East and Africa, By End User
  • Middle East and Africa, By Technology

South America In Vitro Toxicology Testing Market

South America, by Country 

    • Brazil
    • Argentina
    • Rest of South America
  • South America, by Product and Service
  • South America, by Methods
  • South America, by Toxicity Endpoint and Test
  • South America, by End User
  • South America, by Technology

Major Companies

The companies operating in the in vitro toxicology testing market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Covance, Bio-Rad Laboratories, Inc., GE Healthcare, Merck KGaA, Charles River Laboratories International, Inc., Catalent, Inc., Cyprotex, SGS S.A., BioRad Laboratories, QIAGEN N.V., Promega Corporation, Gentronix Limited, BioIVT, MB Research Laboratories, Creative Biolabs, GVK Biosciences Private Limited, Shanghai Medicon Inc., Creative Biorray, and Insphero.

Objectives of this Report:

  • To estimate the market size for the in vitro toxicology testing market on a regional and global basis
  • To identify major segments in the in vitro toxicology testing market and evaluate their market shares and demand
  • To provide a competitive scenario for the market with major developments observed by the key companies in the historic years
  • To evaluate the key factors governing the dynamics of the in vitro toxicology testing market with their potential gravity during the forecast period
  • To evaluate the leading company-wise pricing analysis for the mentioned applications

Key Questioned Answered in the Study:

  • What are major growth drivers and market trends that are impacting the global in vitro toxicology testing market?
  • What is the market size both in terms of value and volume for the global in vitro toxicology testing market?
  • Who are the leading market players and who are the new market players that operate in the global market with an estimated market share?
  • What are the future investment pockets and opportunities in the global in vitro toxicology testing market?
  • Major list of customers and potential futuristic customer list along with an estimated buying volume
  • Impact of COVID-19 on the global in vitro toxicology testing market

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy